#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ewing's sarcoma metastatic Myeloproliferative neoplasm Prostate cancer Follicular lymphoma stage III Pancreatic carcinoma Guillain-Barre syndrome Hairy cell leukaemia Henoch-Schonlein purpura B-cell small lymphocytic lymphoma recurrent Ischaemic stroke Ependymoma Diffuse large B-cell lymphoma recurrent Thalassaemia beta Mucopolysaccharidosis III Chronic myelomonocytic leukaemia More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Basic Information Chondrosarcoma – Treatment Osteosarcoma recurrent – Treatment Langerhans cell sarcoma – Treatment Mantle cell lymphoma stage IV – Treatment Angiosarcoma non-metastatic – Diagnostics Haemophagocytic lymphohistiocytosis – Basic Information Prader-Willi syndrome – Trials in Disease Basal cell naevus syndrome – Basic Information Cytokine release syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Seladelpar Rozanolixizumab Dornase Alfa Vinorelbine Magnesium Sulfate Mosliciguat Morphine Hydrochloride Nemolizumab Etamsylate Azd8421 Cariprazine TEDUGLUTIDE Oxymetazoline Hydrochloride Anhydrous Benzoyl Peroxide Pimecrolimus Dabrafenib Mesylate Daridorexant Tamoxifen Citrate Pp1493 Salmeterol Xinafoate More therapies…

    Learn about Your Condition

    Urticaria cholinergic Optic ischaemic neuropathy Skin ulcer Metabolic surgery Cancer pain Vulvar dysplasia Rhinitis allergic Guttate psoriasis Colon cancer Endocarditis enterococcal Respiratory distress Atrophic vulvovaginitis Breast angiosarcoma metastatic Brain neoplasm malignant Vulvovaginal pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metastases to central nervous system

  • Study on the Effects of Losartan Potassium on Brain Tumors in Patients with Glioblastoma or Brain Metastases from Non-Small-Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Glioblastoma
    Investigated Drugs:
    • Losartan Potassium
    Norway

  • Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET Scans in Patients with New or Recurrent Brain Tumors and Brain Metastases

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Glioma
    Investigated Drugs:
    • Fluciclovine (18F)
    • Fluoroethyltyrosine F-18
    Germany

  • Study of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • HER2 negative breast cancer
    • Metastases to central nervous system
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Austria Spain

  • Study of Patritumab Deruxtecan for Patients with Brain Metastases from Advanced Breast or Lung Cancer and Leptomeningeal Disease from Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Breast cancer metastatic
    • Non-small cell lung cancer
    Investigated Drugs:
    • Patritumab Deruxtecan
    Austria Spain

  • Study on JDQ443 for Patients with KRAS G12C+ Non-Small Cell Lung Cancer and Brain Metastases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    • Non-small cell lung cancer metastatic
    • Non-small cell lung cancer
    Investigated Drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    The Netherlands

  • Study of SGM-101 fluorescent antibody to detect brain metastases from colorectal cancer during surgery

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104
    The Netherlands
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!